NO973283D0 - Konjugater mellom terapeutiske forbindelser og fettsyrer - Google Patents
Konjugater mellom terapeutiske forbindelser og fettsyrerInfo
- Publication number
- NO973283D0 NO973283D0 NO973283A NO973283A NO973283D0 NO 973283 D0 NO973283 D0 NO 973283D0 NO 973283 A NO973283 A NO 973283A NO 973283 A NO973283 A NO 973283A NO 973283 D0 NO973283 D0 NO 973283D0
- Authority
- NO
- Norway
- Prior art keywords
- conjugates
- fatty acids
- therapeutic compounds
- therapeutic
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D475/00—Heterocyclic compounds containing pteridine ring systems
- C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
- C07D475/08—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPN0584A AUPN058495A0 (en) | 1995-01-16 | 1995-01-16 | Therapeutic conjugates 6 |
AUPN0586A AUPN058695A0 (en) | 1995-01-16 | 1995-01-16 | Therapeutic conjugates 8 |
AUPN0580A AUPN058095A0 (en) | 1995-01-16 | 1995-01-16 | Therapeutic conjugates 2 |
AUPN0583A AUPN058395A0 (en) | 1995-01-16 | 1995-01-16 | Therapeutic conjugates 5 |
AUPN0585A AUPN058595A0 (en) | 1995-01-16 | 1995-01-16 | Therapeutic conjugates 7 |
AUPN0581A AUPN058195A0 (en) | 1995-01-16 | 1995-01-16 | Therapeutic conjugates 3 |
AUPN0582A AUPN058295A0 (en) | 1995-01-16 | 1995-01-16 | Therapeutic conjugates 4 |
PCT/AU1996/000015 WO1996022303A1 (en) | 1995-01-16 | 1996-01-15 | Therapeutic compound - fatty acid conjugates |
Publications (2)
Publication Number | Publication Date |
---|---|
NO973283D0 true NO973283D0 (no) | 1997-07-15 |
NO973283L NO973283L (no) | 1997-09-08 |
Family
ID=27560724
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO973283A NO973283L (no) | 1995-01-16 | 1997-07-15 | Konjugater av terapeutisk forbindelse og fettsyre |
Country Status (10)
Country | Link |
---|---|
US (3) | US5952499A (no) |
EP (1) | EP0804459A4 (no) |
JP (1) | JPH11502509A (no) |
BR (1) | BR9607492A (no) |
CA (1) | CA2210500A1 (no) |
FI (1) | FI973002A (no) |
NO (1) | NO973283L (no) |
NZ (1) | NZ298712A (no) |
RU (1) | RU2166512C2 (no) |
WO (1) | WO1996022303A1 (no) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6458772B1 (en) | 1909-10-07 | 2002-10-01 | Medivir Ab | Prodrugs |
US5994392A (en) | 1988-02-26 | 1999-11-30 | Neuromedica, Inc. | Antipsychotic prodrugs comprising an antipsychotic agent coupled to an unsaturated fatty acid |
US5543390A (en) | 1990-11-01 | 1996-08-06 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University | Covalent microparticle-drug conjugates for biological targeting |
US5827819A (en) * | 1990-11-01 | 1998-10-27 | Oregon Health Sciences University | Covalent polar lipid conjugates with neurologically active compounds for targeting |
US6764681B2 (en) * | 1991-10-07 | 2004-07-20 | Biogen, Inc. | Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the CD2/LFA-3 interaction |
AUPN741696A0 (en) * | 1996-01-05 | 1996-01-25 | Commonwealth Scientific And Industrial Research Organisation | Delivery of nucleic acids ii |
US5795909A (en) | 1996-05-22 | 1998-08-18 | Neuromedica, Inc. | DHA-pharmaceutical agent conjugates of taxanes |
US6576636B2 (en) | 1996-05-22 | 2003-06-10 | Protarga, Inc. | Method of treating a liver disorder with fatty acid-antiviral agent conjugates |
DE19631189A1 (de) * | 1996-08-02 | 1998-02-05 | Max Delbrueck Centrum | Neuartige kationische Amphiphile für den liposomalen Gentransfer |
US6197764B1 (en) | 1997-11-26 | 2001-03-06 | Protarga, Inc. | Clozapine compositions and uses thereof |
DE69927831T2 (de) * | 1998-08-31 | 2006-07-20 | Biogen, Inc., Cambridge | Modulierung von gedächtnis-effector- zellen unter verwendung eines cd2-bindungsagens |
AUPP751398A0 (en) * | 1998-12-04 | 1999-01-07 | Commonwealth Scientific And Industrial Research Organisation | Methotrexate derivatives |
US7235583B1 (en) * | 1999-03-09 | 2007-06-26 | Luitpold Pharmaceuticals, Inc., | Fatty acid-anticancer conjugates and uses thereof |
US7238368B2 (en) | 1999-04-23 | 2007-07-03 | Alza Corporation | Releasable linkage and compositions containing same |
EP1579874A3 (en) * | 1999-04-23 | 2006-01-25 | ALZA Corporation | Conjugate having a cleavable linkage for use in a liposome |
US6765019B1 (en) * | 1999-05-06 | 2004-07-20 | University Of Kentucky Research Foundation | Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids |
BR0010909A (pt) * | 1999-05-24 | 2002-02-19 | Sankyo Co | Composição farmacêutica, agente que tem atividade indutora de apoptose, e, uso de um anticorpo fas anti-humano |
GB9930026D0 (en) * | 1999-12-21 | 2000-02-09 | Univ Sheffield | Novel compounds of unsaturated fatty acids |
US6485740B1 (en) * | 2000-03-14 | 2002-11-26 | Yutoku Pharmaceutical Ind., Co., Ltd. | Transdermal methotrexate preparations |
AU2002305099A1 (en) * | 2001-03-23 | 2002-10-08 | Protarga, Inc. | Fatty alcohol drug conjugates |
US8552054B2 (en) * | 2001-03-23 | 2013-10-08 | Luitpold Pharmaceuticals, Inc. | Fatty amine drug conjugates |
BR0210179A (pt) * | 2001-06-05 | 2004-04-27 | Control Delivery Sys Inc | Compostos analgésicos de liberação sustentada |
CA2454618C (en) * | 2001-07-24 | 2012-04-03 | Biogen Idec Ma, Inc. | Methods for treating or preventing sclerotic disorders using cd2-binding agents |
US7125568B2 (en) | 2001-08-23 | 2006-10-24 | Sung Michael T | Lipophilic drug compositions |
US7045543B2 (en) | 2001-11-05 | 2006-05-16 | Enzrel Inc. | Covalent conjugates of biologically-active compounds with amino acids and amino acid derivatives for targeting to physiologically-protected sites |
AU2004277400B2 (en) * | 2003-09-30 | 2009-01-22 | Shire Llc | Pharmaceutical compositions for prevention of overdose or abuse |
BRPI0507404A (pt) * | 2004-02-06 | 2007-06-26 | Astellas Us Llc | método de tratamento de um indivìduo que tem psorìase e kit |
CN1997756A (zh) * | 2004-05-04 | 2007-07-11 | 杰耐萨斯药品公司 | 单倍型标记和利用其确定对于治疗的反应的方法 |
WO2005115436A1 (en) * | 2004-05-07 | 2005-12-08 | Astellas Us Llc | Soluble lfa-3 polypeptide for treating viral disorders |
US20060078580A1 (en) * | 2004-10-08 | 2006-04-13 | Mediquest Therapeutics, Inc. | Organo-gel formulations for therapeutic applications |
US7740875B2 (en) * | 2004-10-08 | 2010-06-22 | Mediquest Therapeutics, Inc. | Organo-gel formulations for therapeutic applications |
US8044100B2 (en) | 2004-12-22 | 2011-10-25 | Bellus Health Inc. | Methods and compositions for treating amyloid-related diseases |
CA2634027A1 (en) * | 2005-12-16 | 2007-07-05 | James A. Glazier | Sub-micron surface plasmon resonance sensor systems |
KR101742179B1 (ko) | 2006-10-12 | 2017-05-31 | 비에이치아이 리미티드 파트너쉽 | 3-아미노-1-프로판설폰산을 전달하기 위한 방법, 화합물, 조성물 및 비히클 |
US8710070B2 (en) * | 2008-03-27 | 2014-04-29 | University Of Kentucky Research Foundation | Opioid-ketamine and norketamine codrug combinations for pain management |
WO2009121018A2 (en) * | 2008-03-27 | 2009-10-01 | University Of Kentucky Research Foundation | Opioid-nornicotine codrugs for pain management |
US20110178024A1 (en) | 2008-09-29 | 2011-07-21 | Ben Gurion University Of The Negev Research And Development Authority | Amyloid beta-peptides and methods of use thereof |
JP5706825B2 (ja) * | 2008-10-17 | 2015-04-22 | シグネーチャー セラピューティクス, インク.Signature Therapeutics, Inc. | フェノール性オピオイドの放出が減弱された医薬組成物 |
WO2010063080A1 (en) * | 2008-12-05 | 2010-06-10 | Commonwealth Scientific And Industrial Research Organisation | Amphiphile prodrugs |
US20100240883A1 (en) * | 2009-03-18 | 2010-09-23 | Nian Wu | Lipid-drug conjugates for drug delivery |
NZ601550A (en) | 2010-02-03 | 2014-03-28 | Mivenion Gmbh | Polyanionic multivalent macromolecules for intracellular targeting of proliferation and protein synthesis |
IN2014DN03009A (no) * | 2011-10-26 | 2015-05-08 | Kempharm Inc | |
WO2016089951A1 (en) | 2014-12-02 | 2016-06-09 | Kempharm, Inc. | Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of oxymorphone, prodrugs, methods and making and use thereof |
AU2016379454B2 (en) | 2015-12-23 | 2021-01-28 | The University Of British Columbia | Lipid-linked prodrugs |
JP2020523035A (ja) | 2017-06-07 | 2020-08-06 | エーディーアールエックス, インコーポレイテッド | タウ凝集阻害剤 |
WO2019036725A2 (en) | 2017-08-18 | 2019-02-21 | Adrx, Inc. | PEPTIDE INHIBITORS OF TAU AGGREGATION |
RU2713838C1 (ru) * | 2019-04-23 | 2020-02-07 | Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр онкологии имени Н.Н. Блохина" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ онкологии им. Н.Н. Блохина" Минздрава России) | Способ анестезиологического обеспечения при селективной доставке химиопрепарата к сетчатке глаза при лечении интраокулярной ретинобластомы у детей |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3686238A (en) * | 1970-01-19 | 1972-08-22 | Syntex Corp | Glycerol esterified with 2-naphthyl-acetic acids and fatty acids |
US5223263A (en) * | 1988-07-07 | 1993-06-29 | Vical, Inc. | Liponucleotide-containing liposomes |
US4939174A (en) * | 1988-02-26 | 1990-07-03 | Shashoua Victor E | Appetite suppression with dopamine-fatty acid conjugates |
DE3904119A1 (de) * | 1989-02-11 | 1990-08-16 | Hoechst Ag | Polymerfixiertes methotrexat, verfahren zur herstellung und verwendung |
US5583198A (en) * | 1989-12-22 | 1996-12-10 | Commonwealth Scientific And Industrial Research Organization | Amino acids, peptides or derivatives thereof coupled to fats |
WO1991009837A1 (en) * | 1989-12-22 | 1991-07-11 | Commonwealth Scientific And Industrial Research Organisation | Amino acids, peptides or derivatives thereof coupled to fats |
JPH0421694A (ja) * | 1990-05-16 | 1992-01-24 | Asahi Chem Ind Co Ltd | 新規なヌクレオシド―リン脂質複合体 |
JPH06509559A (ja) * | 1991-03-19 | 1994-10-27 | セラピューティック パッチ リサーチ エヌ.ブイ. | 膜透過エンハンサーとしてのアミノアルコール誘導体組成物及び方法 |
US5955080A (en) * | 1991-07-26 | 1999-09-21 | Commonwealth Scientific And Industrial Research Organisation | Self-adjuvanting peptide vaccine delivery system and production thereof |
DE4311987A1 (de) * | 1993-04-07 | 1994-10-13 | Schering Ag | Neue Glucocorticoide |
US5792786A (en) * | 1993-08-02 | 1998-08-11 | Commonwealth Scientific And Industrial Research Organisation | Non-steroidal anti-inflammatory fatty acid conjugates and their therapeutic use thereof |
-
1996
- 1996-01-15 CA CA002210500A patent/CA2210500A1/en not_active Abandoned
- 1996-01-15 JP JP8521914A patent/JPH11502509A/ja not_active Ceased
- 1996-01-15 EP EP96900469A patent/EP0804459A4/en not_active Withdrawn
- 1996-01-15 BR BR9607492A patent/BR9607492A/pt not_active IP Right Cessation
- 1996-01-15 NZ NZ298712A patent/NZ298712A/xx unknown
- 1996-01-15 US US08/875,098 patent/US5952499A/en not_active Expired - Fee Related
- 1996-01-15 RU RU97113473/04A patent/RU2166512C2/ru not_active IP Right Cessation
- 1996-01-15 WO PCT/AU1996/000015 patent/WO1996022303A1/en not_active Application Discontinuation
-
1997
- 1997-07-15 FI FI973002A patent/FI973002A/fi unknown
- 1997-07-15 NO NO973283A patent/NO973283L/no not_active Application Discontinuation
-
1999
- 1999-04-12 US US09/289,715 patent/US6281376B1/en not_active Expired - Fee Related
-
2001
- 2001-05-24 US US09/863,385 patent/US20030023104A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
RU2166512C2 (ru) | 2001-05-10 |
FI973002A (fi) | 1997-08-19 |
BR9607492A (pt) | 1999-06-29 |
EP0804459A4 (en) | 1999-05-26 |
US6281376B1 (en) | 2001-08-28 |
EP0804459A1 (en) | 1997-11-05 |
US5952499A (en) | 1999-09-14 |
NZ298712A (en) | 1998-12-23 |
WO1996022303A1 (en) | 1996-07-25 |
CA2210500A1 (en) | 1996-07-25 |
JPH11502509A (ja) | 1999-03-02 |
FI973002A0 (fi) | 1997-07-15 |
US20030023104A1 (en) | 2003-01-30 |
NO973283L (no) | 1997-09-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO973283D0 (no) | Konjugater mellom terapeutiske forbindelser og fettsyrer | |
DE69634714D1 (de) | Therapeutisches Ultraschallgerät | |
BR9602637A (pt) | Cateter | |
FI951101A0 (fi) | 5-vinyyli- ja 5-etinyylikinoloni- ja -naftyridonikarboksyylihapot | |
DE59608428D1 (de) | Ballenpresse | |
DE29515629U1 (de) | Ballenpresse | |
DE29511023U1 (de) | Ballenpresse | |
DE69619022D1 (de) | Ballenpresse | |
DE29509182U1 (de) | Matratze | |
DE59604289D1 (de) | Ungesättigter Ester | |
DE29508739U1 (de) | Ballenpresse | |
DE29509874U1 (de) | Matratze | |
NO962385L (no) | Terapeutiske amider | |
DE19648723B4 (de) | 4-Aminophenol-Derivate | |
KR960033582U (ko) | 지압구 | |
KR970008153U (ko) | 지압구 | |
DE29505390U1 (de) | Ausstellungskörper | |
KR960028346U (ko) | 쑥뜸기 | |
DE29503674U1 (de) | Zerlegbarer Patienten-Lothublifter in Leichtausführung | |
DE69623690D1 (de) | Ballenpresse | |
DE29503798U1 (de) | Matratze | |
DE29517024U1 (de) | Matratze | |
KR970004277U (ko) | 지압구 | |
KR970012148U (ko) | 지압구 | |
KR950026319U (ko) | 치료환자용 팬티 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |